CYBIN INC.
For the period ended Mar 31, 2025. Filed Jul 1, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2025 · Filed Jul 1, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.3 · Technology Programs
Technology Programs
The Company has historically had two technology programs (a) Digital Therapy Platform which was intended to support patients undergoing psychedelic therapies to memorialize the learning from their treatment sessions and to assist with the integration of such learnings into the patient’s psychotherapy program; and (b) Kernel Collaboration to evaluate the use of wearable neuroimaging technology during psychedelic therapy. In March 2025, the Company decided to not proceed with its technology programs in order to prioritize the progression of its clinical development programs. The Company had previously indicated that it was evaluating the path forward for both the Digital Therapy Platform and the Kernel Collaboration. The Company no longer expects to complete the technology programs and is expecting to spend $NIL on these programs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.